A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Roswell Park Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Boston Children's Hospital
Thomas Jefferson University
Dartmouth-Hitchcock Medical Center
Masonic Cancer Center, University of Minnesota
Duke University
Fadoi Foundation, Italy
Thomas Jefferson University
Thomas Jefferson University
Fred Hutchinson Cancer Center
AstraZeneca
Ottawa Hospital Research Institute
Medical College of Wisconsin
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
AstraZeneca
Virginia Commonwealth University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Alliance Foundation Trials, LLC.
Sobi, Inc.
M.D. Anderson Cancer Center
Celgene
OHSU Knight Cancer Institute
Alexion Pharmaceuticals, Inc.
Albert Einstein College of Medicine
Pfizer
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Sierra Oncology LLC - a GSK company
M.D. Anderson Cancer Center
Hoffmann-La Roche
Novartis
Hoffmann-La Roche
Merck Sharp & Dohme LLC
Dana-Farber Cancer Institute
SWOG Cancer Research Network
University of Alabama at Birmingham
Duke University
National Cancer Institute (NCI)
Kyntra Bio
King Hussein Cancer Center
Celgene
Roswell Park Cancer Institute
Insel Gruppe AG, University Hospital Bern
Hoffmann-La Roche
West Virginia University
Hoffmann-La Roche